Merck Signs MoU with Cyto-Facto to Advance Cell and Gene Therapy Manufacturing in APAC
Merck has signed a non-binding Memorandum of Understanding (MoU) with Cyto-Facto Inc., a Contract Development and Manufacturing Organization (CDMO) focused […]
Merck has signed a non-binding Memorandum of Understanding (MoU) with Cyto-Facto Inc., a Contract Development and Manufacturing Organization (CDMO) focused […]
MedRabbits has announced the launch of MedRabbits Clinic, a medical facility designed to provide consultations, diagnostics, and essential treatments under […]
P&G SEHAT, the healthcare-focused Corporate Social Responsibility (CSR) initiative of Procter & Gamble Health Limited (P&G Health), is supporting primary […]
The US Food and Drug Administration (FDA) has approved leucovorin for the treatment of cerebral folate deficiency (CFD), a rare […]
BioNTech founders Ugur Sahin and Oezlem Tuereci have announced plans to step down from their roles at the German biotechnology […]
Global eye care leader Alcon has announced the launch of the Hydrus® Microstent in India, introducing a minimally invasive surgical […]
A 300-bed super-specialty hospital founded by former Indian cricket captain Kapil Dev was inaugurated by Uttar Pradesh Chief Minister Yogi […]
Mahanadi Coalfields Limited (MCL) has signed Memoranda of Understanding (MoUs) worth ₹46.51 crore to strengthen healthcare infrastructure and diagnostic capacity […]
Prime Minister Narendra Modi will visit Rajasthan on February 28 to launch a nationwide Human Papillomavirus (HPV) vaccination drive aimed […]
Aurobindo Pharma Limited announced the completion of a United States Food and Drug Administration (US FDA) inspection at Unit-I of […]
The Delhi Cabinet has approved the inclusion of widows and persons with disabilities receiving government financial assistance under the Ayushman […]
Glenmark Pharmaceuticals Ltd. has announced that its wholly owned subsidiary, Glenmark Pharmaceuticals Inc., USA, will launch Sodium Phosphate Injection in […]
The US Food and Drug Administration (FDA) has approved the first-line use of Boehringer Ingelheim’s lung cancer therapy zongertinib for […]